Advertisement

PharmacoEconomics

, Volume 16, Issue 4, pp 417–417 | Cite as

A Review of Quality of Life in Alzheimer’s Disease

Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects
  • Stephen P. McKenna
  • Lynda C. Doward
Correspondence

Keywords

Life Satisfaction Adis International Limited Assess Drug Effect Galen Research Sessed Quality 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Greer M, Monteban H. A review of quality of life in Alzheimer’s disease. Parts 1 and 2: issues in assessing disease impact and drug effects [letter]. Pharmacoeconomics 1999; 15 (6): 641PubMedCrossRefGoogle Scholar
  2. 2.
    Walker MD, Salek SS, Bayer AJ. A review of quality of life in Alzheimer’s disease. Part 1: issues in assessing disease impact. Pharmacoeconomics 1998; 14 (5): 499–530PubMedCrossRefGoogle Scholar
  3. 3.
    Salek SS, Walker MD, Bayer AJ. A review of quality of life in Alzheimer’s disease. Part 2: issues in assessing drug effects. Pharmacoeconomics 1998; 14 (6): 613–27PubMedCrossRefGoogle Scholar
  4. 4.
    Salek SS, Walker MD, Bayer AJ. A review of quality of life in Alzheimer’s disease. Parts 1 and 2: issues in assessing disease impact and drug effects [letter]. Pharmacoeconomics 1999; 15: 641–4CrossRefGoogle Scholar
  5. 5.
    Whiteneck GG. Measuring what matters: key rehabilitation outcomes. Arch Phys Med Rehabil 1994; 75: 1073–6PubMedCrossRefGoogle Scholar
  6. 6.
    Gill TM, Feinstein AR. A critical appraisal of the quality of quality of life measurements. JAMA 1994; 272: 619–25PubMedCrossRefGoogle Scholar
  7. 7.
    Heinemann AW, Whiteneck GG. Relationships among impairment, disability, handicap and life satisfaction in persons with traumatic brain injury. J Head Trauma Rehabil 1995; 10: 54–63CrossRefGoogle Scholar
  8. 8.
    Doward LC, McKenna SP. Evolution of quality of life assessment. In: Rajagopalan R, Sheretz EF, Anderson RT, editoris. Care management of skin diseases: life quality and economic impact. New York: Marcel Dekker, 1997: 9–33Google Scholar
  9. 9.
    Doward LC. The development of the Alzheimer’s Carers’ Quality of Life Instrument (ACQLI) [abstract no. 88]. Qual Life Res 1997; 6 Suppl. 7–8: 639Google Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Stephen P. McKenna
    • 1
  • Lynda C. Doward
    • 1
  1. 1.Galen ResearchManchesterEngland

Personalised recommendations